Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rankning i aktier #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Aktiekurs
$4.84
Marknadsvärde
$633.18M
Förändring (1 dag)
3.20%
Förändring (1 år)
0.00%
Land
GB
Handel Exscientia plc (EXAI)

Kategori

Healthcare
P/S-tal för Exscientia plc (EXAI)
P/S-tal per April 2026 TTM: 23.78
Enligt Exscientia plc senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 23.78. I slutet av 2022 hade företaget ett P/S-tal på 24.27.
Historik för P/S-tal för Exscientia plc från 2019 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
2026 (TTM) 23.78 -23.72%
2023 31.18 28.46%
2022 24.27 -72.05%
2021 86.85 -52.06%
2020 181.16 -12.07%
2019 206.03 0.00%
P/S-tal för liknande företag eller konkurrenter
Företag P/S-tal Skillnad i P/S-tal Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.32 -86.04%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.42 -60.38%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.60 -76.47%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.36 -73.27%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -87.22%
AU